| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -9% |
| 3Y CAGR | +7.0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +459% |
| 3Y CAGR | +27% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,874.80 -115.60 (2.32%) | 22,802.96 | 31.02 | 5.43 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,753.00 -39.50 (0.51%) | 19,479.00 | 114.84 | 22.32 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,480.50 -19.20 (0.77%) | 18,989.62 | 28.01 | 5.29 | ||
Natco PharmaNATCOPHARM | ₹903.15 -48.55 (5.10%) | 17,055.74 | 12.02 | 1.85 |